Felix Zijlstra1. Show Affiliations » 1. Thorax Center, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands. f.zijlstra@thorax.umcg.nl
Abstract
Entities: Chemical
Mesh： See more » AbciximabAngioplasty, Balloon, Coronary/adverse effectsAngioplasty, Balloon, Coronary/instrumentationAngioplasty, Balloon, Coronary/mortalityAntibodies, Monoclonal/administration & dosageAntibodies, Monoclonal/adverse effectsCoronary Artery Disease/mortalityCoronary Artery Disease/therapyEptifibatideHemorrhage/chemically inducedHospital MortalityHumansImmunoglobulin Fab Fragments/administration & dosageImmunoglobulin Fab Fragments/adverse effectsInjections, IntravenousMyocardial Infarction/etiologyMyocardial Infarction/mortalityMyocardial Infarction/prevention & controlPeptides/administration & dosagePeptides/adverse effectsPlatelet Aggregation Inhibitors/administration & dosagePlatelet Aggregation Inhibitors/adverse effectsRisk AssessmentStentsTime FactorsTirofibanTreatment OutcomeTyrosine/administration & dosageTyrosine/adverse effectsTyrosine/analogs & derivatives
Substances： See more » Antibodies, MonoclonalImmunoglobulin Fab FragmentsPeptidesPlatelet Aggregation InhibitorsTyrosineTirofibanEptifibatideAbciximab
Year: 2009 PMID： 19156883 DOI： 10.1002/ccd.21954
Source DB: PubMed Journal: Catheter Cardiovasc Interv ISSN： 1522-1946 Impact factor: 2.692